Loading...
Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer
OX40 is a costimulatory receptor that potentiates proliferation, survival, memory formation, and effector function of CD4(+) and CD8(+) T-cells, while overcoming the suppressive activity of regulatory T-cells (Tregs). Here, we explored the combination of an OX40L fusion protein (OX40L-FP) with a pox...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5710887/ https://ncbi.nlm.nih.gov/pubmed/29207606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19967 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|